Wengel Kathryn E 4

What Happened

• Kathryn E. Wengel, a director of Labcorp Holdings Inc. (LH), was granted 773 restricted stock units (RSUs) on February 10, 2026. The award was reported as an acquisition of a derivative security at $0.00 (no cash paid). Each RSU represents the contingent right to receive one share of Labcorp common stock; the RSUs vest in full on February 10, 2027.

Key Details

• Transaction date: 2026-02-10; reported on Form 4 filed 2026-02-12 (filed within the standard reporting window).
• Instrument and amount: 773 Restricted Stock Units (derivative award) acquired at $0.00.
• Shares/units held after transaction: 773 RSUs (aggregate number held by the reporting person per filing).
• Footnotes: F1—each RSU converts to one share; F2—vests fully 2027-02-10; F3—figure is aggregate RSUs held. Exhibit 24 (Power of Attorney) included with filing.

Context

• This was a compensation award (not an open-market purchase or sale). RSU grants are common director compensation and do not necessarily indicate immediate buying or selling sentiment. Once vested, RSUs typically convert to shares and may be subject to tax withholding or sale for taxes; no sale or exercise was reported here.